Evaluation of the Brain Delivery Efficacy via Transporter-Mediated Approach The quantitative evaluation of brain delivery efficacy via transporter-mediated approach based on the CNS pharmacokinetic principles is critical for understanding the usability of the strategy and decision-making on further development of the transporter-utilizing (pro)drug and nanocarriers
Lilly also reported that weight loss continued through the duration of the study without a clear plateau, suggesting the possibility of sustained benefit with longer-term use
Common causes include puberty, aging, anabolic steroid use, certain prescription medications, marijuana use, obesity, and underlying medical conditions
The "LR3" modification (a substitution at position 3 and an arginine extension) reduces IGF-1 LR3's affinity for IGF-binding proteins (IGFBPs)
Ronaldson PT, Bendayan R
It is hoped that over time, a decline in obesity may correlate with fewer cases of type 2 diabetes in the future